Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Agios Pharmaceuticals Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
AGIO
Nasdaq
8731
https://www.agios.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Agios Pharmaceuticals Inc
Agios to Present at the Leerink Partners Global Biopharma ConferenceĀ on March 12, 2024
- Mar 5th, 2024 12:00 pm
Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating
- Feb 26th, 2024 8:12 pm
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
- Feb 23rd, 2024 3:45 pm
Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024
- Feb 22nd, 2024 12:00 pm
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript
- Feb 20th, 2024 1:24 pm
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Reported And Analysts Have Been Cutting Their Estimates
- Feb 18th, 2024 12:14 pm
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Analysts Just Slashed This Year's Estimates
- Feb 17th, 2024 12:12 pm
Agios (AGIO) Q4 Earnings & Revenues Fall Short of Estimates
- Feb 16th, 2024 2:38 pm
Q4 2023 Agios Pharmaceuticals Inc Earnings Call
- Feb 16th, 2024 3:15 am
Agios Pharmaceuticals (AGIO) Reports Q4 Loss, Misses Revenue Estimates
- Feb 15th, 2024 1:25 pm
Agios Pharmaceuticals Inc (AGIO) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
- Feb 15th, 2024 12:59 pm
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
- Feb 15th, 2024 12:00 pm
Drug, Biotech Stock Q4 Earnings Due on Feb 15: ALNY, BPMC & More
- Feb 14th, 2024 3:12 pm
Earnings Preview: Agios Pharmaceuticals (AGIO) Q4 Earnings Expected to Decline
- Feb 8th, 2024 3:00 pm
Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024
- Feb 2nd, 2024 12:00 pm
Agios Pharmaceuticals Inc Director Jacqualyn Fouse Sells 10,722 Shares
- Jan 25th, 2024 12:02 am
Insider Sell: CEO Brian Goff Sells 12,066 Shares of Agios Pharmaceuticals Inc (AGIO)
- Jan 12th, 2024 12:15 am
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
- Jan 8th, 2024 12:00 pm
Agios (AGIO) Up 5% on Upbeat Data From Thalassemia Study
- Jan 4th, 2024 4:19 pm
Biotech Stock Roundup: VYGR Gains From NVS Deal, AGIO Up on Study Data & More
- Jan 4th, 2024 2:05 pm
Scroll